JP2004538477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004538477A5 JP2004538477A5 JP2003520382A JP2003520382A JP2004538477A5 JP 2004538477 A5 JP2004538477 A5 JP 2004538477A5 JP 2003520382 A JP2003520382 A JP 2003520382A JP 2003520382 A JP2003520382 A JP 2003520382A JP 2004538477 A5 JP2004538477 A5 JP 2004538477A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- level
- antibody
- time interval
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31322401P | 2001-08-17 | 2001-08-17 | |
| US31322101P | 2001-08-17 | 2001-08-17 | |
| US33498701P | 2001-10-23 | 2001-10-23 | |
| PCT/US2002/026321 WO2003015617A2 (en) | 2001-08-17 | 2002-08-16 | Assay method for alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009208372A Division JP5162553B2 (ja) | 2001-08-17 | 2009-09-09 | アルツハイマー病のアッセイ方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004538477A JP2004538477A (ja) | 2004-12-24 |
| JP2004538477A5 true JP2004538477A5 (https=) | 2006-01-05 |
| JP4511830B2 JP4511830B2 (ja) | 2010-07-28 |
Family
ID=27405654
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003520382A Expired - Lifetime JP4511830B2 (ja) | 2001-08-17 | 2002-08-16 | アルツハイマー病のアッセイ方法 |
| JP2009208372A Expired - Lifetime JP5162553B2 (ja) | 2001-08-17 | 2009-09-09 | アルツハイマー病のアッセイ方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009208372A Expired - Lifetime JP5162553B2 (ja) | 2001-08-17 | 2009-09-09 | アルツハイマー病のアッセイ方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1416965B8 (https=) |
| JP (2) | JP4511830B2 (https=) |
| AT (1) | ATE381346T1 (https=) |
| CA (1) | CA2457145C (https=) |
| CY (1) | CY1107901T1 (https=) |
| DE (1) | DE60224200T2 (https=) |
| DK (1) | DK1416965T3 (https=) |
| ES (1) | ES2295401T3 (https=) |
| PT (1) | PT1416965E (https=) |
| WO (1) | WO2003015617A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1257584T1 (de) | 2000-02-24 | 2003-05-28 | Lilly Co Eli | Humanisierte antikörper, die amyloid beta peptid demarkieren |
| PT1944040E (pt) | 2001-08-17 | 2012-10-31 | Univ Washington | Método de avaliação para a doença de alzheimer |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| ATE468886T1 (de) | 2003-02-10 | 2010-06-15 | Applied Molecular Evolution | Abeta-bindende moleküle |
| EP1480041A1 (en) * | 2003-05-22 | 2004-11-24 | Innogenetics N.V. | Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease |
| GB0519398D0 (en) * | 2005-09-23 | 2005-11-02 | Antisoma Plc | Biological materials and uses thereof |
| US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
| HRP20140240T4 (hr) | 2005-11-30 | 2017-02-24 | Abbvie Inc. | Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| DK2121754T3 (en) | 2007-01-18 | 2015-02-23 | Lilly Co Eli | Pegylated amyloid BETA FAB |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| WO2010093001A1 (ja) * | 2009-02-13 | 2010-08-19 | 国立大学法人大阪大学 | アルツハイマー病の診断方法および診断薬 |
| BR112012014060B8 (pt) | 2009-12-11 | 2021-07-27 | Araclon Biotech Sl | método para o diagnóstico da doença de alzheimer em um sujeito, para detecção da disfunção cognitiva branda ou para diferenciar a doença de alzheimer da disfunção cognitiva branda |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| EP2511296A1 (en) | 2011-04-12 | 2012-10-17 | Araclón Biotech, S. L. | Antibody, kit and method for determination of amyloid peptides |
| IL245703B (en) * | 2013-11-20 | 2022-07-01 | Univ Iowa Res Found | Methods and compositions for treating amyloid deposits |
| CN109187981A (zh) * | 2018-08-01 | 2019-01-11 | 万东山 | 一种快速检测β-淀粉样蛋白的量子点免疫层析试纸条与应用 |
| KR102496845B1 (ko) * | 2018-08-08 | 2023-02-08 | 서울대학교산학협력단 | 진단 지표로서 베타-아밀로이드 수준과 함께 혈장 타우 수준을 사용하는 알츠하이머병의 진단 및 치료 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69334337D1 (de) * | 1992-10-26 | 2010-08-26 | Elan Pharm Inc | Verfahren zur Identifizierung von Hemmstoffverbindungen der Freisetzung von Beta-Amyloidpeptid (BAP) |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US7964192B1 (en) * | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| US6730778B2 (en) * | 1997-12-19 | 2004-05-04 | Pharmacia And Upjohn Company | Human sel-10 polypeptides and polynucleotides that encode them |
| DE1257584T1 (de) * | 2000-02-24 | 2003-05-28 | Lilly Co Eli | Humanisierte antikörper, die amyloid beta peptid demarkieren |
-
2002
- 2002-08-16 PT PT02766022T patent/PT1416965E/pt unknown
- 2002-08-16 CA CA2457145A patent/CA2457145C/en not_active Expired - Fee Related
- 2002-08-16 ES ES02766022T patent/ES2295401T3/es not_active Expired - Lifetime
- 2002-08-16 JP JP2003520382A patent/JP4511830B2/ja not_active Expired - Lifetime
- 2002-08-16 DE DE60224200T patent/DE60224200T2/de not_active Expired - Lifetime
- 2002-08-16 AT AT02766022T patent/ATE381346T1/de active
- 2002-08-16 DK DK02766022T patent/DK1416965T3/da active
- 2002-08-16 EP EP02766022A patent/EP1416965B8/en not_active Expired - Lifetime
- 2002-08-16 WO PCT/US2002/026321 patent/WO2003015617A2/en not_active Ceased
-
2008
- 2008-03-07 CY CY20081100267T patent/CY1107901T1/el unknown
-
2009
- 2009-09-09 JP JP2009208372A patent/JP5162553B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004538477A5 (https=) | ||
| Jusko et al. | Plasma and tissue protein binding of drugs in pharmacokinetics | |
| JP2002533680A5 (https=) | ||
| JP2006516116A5 (https=) | ||
| Pickup et al. | Serum sialic acid concentration and coronary heart disease in NIDDM | |
| JP2004532817A5 (https=) | ||
| KR101155294B1 (ko) | 면역특이적으로 ＢＬｙＳ에 결합하는 항체 | |
| EA200500715A1 (ru) | Новые лекарственные средства для лечения хронического обструктивного заболевания лёгких | |
| US20220402979A1 (en) | Biomarkers and treatments of alzheimer's disease and mild cognitive impairment | |
| JP2005523335A5 (https=) | ||
| JP2009173684A (ja) | 腎臓結石疾患の予防のための希土類化合物の使用 | |
| JP2004517824A5 (https=) | ||
| AU2024201099A1 (en) | Treatment and prevention of Alzheimer's Disease (AD) | |
| JP2023531069A5 (https=) | ||
| CA2457145A1 (en) | Assay method for alzheimer's disease | |
| CN112312917A (zh) | 用于治疗幻觉及其相关病症的方法和组合物 | |
| JP6725515B2 (ja) | 小分子を用いた鉄欠乏生物における生理機能の回復 | |
| JP2006505536A5 (https=) | ||
| Massol et al. | Letter to the Editor regarding'Impact of Continuous Renal Replacement Therapy with Polyacrylonitrile-Derived Filter on Caspofungin Concentration: A Retrospective Study' | |
| Zhu et al. | Detection of IgE antibodies specific for 1-phenyl-2, 3-dimethyl-3-pyrazoline-5-one by RAST: a serological diagnostic method for sensitivity to pyrazoline drugs | |
| Sha et al. | In vivo electroporation of a new gene vaccine encoding ten repeats of Aβ3-10 prevents brain Aβ deposition and delays cognitive impairment in young Tg-APPswe/PSEN1dE9 mice | |
| DE60336063D1 (de) | Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren | |
| EP3137094A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| WO2002026193A3 (en) | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | |
| JP5024695B2 (ja) | 腎疾患治療剤 |